Laura Codarri-Deak

Title: Laura Codarri-Deak: Innovator in Bispecific Antibodies

Introduction

Laura Codarri-Deak is a prominent inventor based in Schlieren, Switzerland. She has made significant contributions to the field of biomedicine, particularly in the development of bispecific antibodies. With a total of 3 patents to her name, her work is paving the way for innovative therapeutic solutions.

Latest Patents

One of her latest patents focuses on bispecific antibodies that are specific for PD1 and TIM3. This invention relates to antibodies that comprise a first antigen-binding site that specifically binds to PD1 and a second antigen-binding site that specifically binds to TIM3. Notably, the bispecific antibody binds to TIM3 with a lower binding affinity compared to its binding to PD1. The patent also details methods for producing these molecules and their potential applications in therapy.

Career Highlights

Throughout her career, Laura has worked with notable companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to refine her expertise in antibody development and biotherapeutics.

Collaborations

Laura has collaborated with esteemed colleagues such as Georg Fertig and Jens Fischer. These partnerships have contributed to her innovative research and the advancement of her patented technologies.

Conclusion

Laura Codarri-Deak is a trailblazer in the field of bispecific antibodies, with her inventions holding promise for future therapeutic applications. Her work exemplifies the impact of innovation in biomedicine and the importance of collaboration in scientific research.